Publication:
Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats.

dc.contributor.authorRuiz-Malagon, Antonio Jesus
dc.contributor.authorRodriguez-Sanchez, Maria Jose
dc.contributor.authorRodriguez-Sojo, Maria Jesus
dc.contributor.authorVezza, Teresa
dc.contributor.authorPischel, Ivo
dc.contributor.authorAlgieri, Francesca
dc.contributor.authorRodriguez-Cabezas, Maria Elena
dc.contributor.authorRodriguez-Nogales, Alba
dc.contributor.authorGalvez, Julio
dc.contributor.funderJunta de Andalucia
dc.contributor.funderSpanish Ministry of Economy and Competitivity
dc.contributor.funderInstituto de Salud Carlos III (ISCIII)
dc.date.accessioned2023-05-03T13:44:41Z
dc.date.available2023-05-03T13:44:41Z
dc.date.issued2022-08-11
dc.description.abstractEthnopharmacological relevance:Serpylli herba extract (SHE), composed of the aerial parts of wild thyme (Thymus serpyllum L.) (Lamiaceae family), is traditionally used in Europe and North Africa to treat diarrhea, gastric ulcers, intestinal parasites and upper respiratory tract infections. Recently, SHE has generated a great interest for irritable bowel syndrome (IBS) management, probably due to its intestinal anti-inflammatory properties shown in experimental colitis and the fact that its active components could preserve the intestinal barrier integrity, which is altered in patients with IBS. Aim of study: We aimed to test the effects of a SHE in a rat experimental model resembling human IBS. Materials and methods: IBS was provoked by deoxycholic acid (DCA). Rats were then treated with SHE (100 mg/kg) or gabapentin (70 mg/kg) and different inflammatory and gut barrier integrity markers were evaluated. Moreover, several gut hypersensitivity and hyperalgesia determinations were performed. Results: SHE improved referred pain and visceral hypersensitivity. Additionally, SHE enhanced immune status by downregulating of the expression of the pro-inflammatory mediators Il-1β, Il-6, Ifn-γ, Tlr-4, and the inducible enzyme Cox-2, thus inducing visceral analgesia, and promoting the restore of the gut barrier function by upregulating the mucins Muc-2 and Muc-3. These anti-inflammatory effects could be related to its action on mast cells since it significantly inhibited the β-Hexosaminidase production in RBL-2H3 cells. Lastly, SHE also seems to modulate the serotonin pathway by restoring the altered expression of the 5-HT receptors Htr-3 and Htr-4. Conclusion: SHE could be considered a potential new treatment for IBS, since it ameliorates hypersensitivity, visceral hyperalgesia, and inflammation. These beneficial effects may be due to the inhibition of mast cells degranulation and serotonin pathway.
dc.description.versionSi
dc.identifier.citationRuiz-Malagón AJ, Rodríguez-Sanchez MJ, Rodríguez-Sojo MJ, Vezza T, Pischel I, Algieri F, et al.. Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats. Front Pharmacol. 2022 Sep 2;13:967644.
dc.identifier.doi10.3389/fphar.2022.967644
dc.identifier.issn1663-9812
dc.identifier.pmcPMC9479127
dc.identifier.pmid36120292
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479127/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2022.967644/pdf
dc.identifier.urihttp://hdl.handle.net/10668/20711
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number967644
dc.provenanceRealizada la curación de contenido 04/09/2024
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.projectIDAGR-6826
dc.relation.projectIDCTS 164
dc.relation.projectIDSAF 2011-29648
dc.relation.projectIDPI19/01058
dc.relation.projectIDPI20/01447
dc.relation.projectIDCIBER-EHD
dc.relation.publisherversionhttps://doi.org/10.3389/fphar.2022.967644
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectIBS rat model
dc.subjectSerpylli herba
dc.subjectT. serpyllum L.
dc.subjectintestine anti inflammatory activity
dc.subjectvisceral analgesia
dc.subject.decsColitis
dc.subject.decsDiarrea
dc.subject.decsDolor referido
dc.subject.decsGabapentina
dc.subject.decsHexosaminidasas
dc.subject.decsHiperalgesia
dc.subject.decsInflamación
dc.subject.decsMastocitos
dc.subject.decsMucinas
dc.subject.decsParásitos
dc.subject.decsSerotonina
dc.subject.decsSíndrome del colon irritable
dc.subject.decsThymus (Planta)
dc.subject.decsÚlcera gástrica
dc.subject.meshIrritable Bowel Syndrome
dc.subject.meshHyperalgesia
dc.subject.meshThymus Plant
dc.subject.meshSerotonin
dc.subject.meshGabapentin
dc.subject.meshParasites
dc.subject.meshMast Cells
dc.subject.meshMucins
dc.subject.meshHexosaminidases
dc.subject.meshPain, Referred
dc.subject.meshStomach Ulcer
dc.subject.meshInflammation
dc.subject.meshColitis
dc.subject.meshDiarrhea
dc.titleIntestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC9479127.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Ruiz_IntestinalAnti-inflammatory_MaterialSuplementario.docx
Size:
613.99 KB
Format:
Microsoft Word XML